Cargando…

The chimeric multi-domain proteins mediating specific DNA transfer for hepatocellular carcinoma treatment

AIM: This study was aimed to evaluate the therapeutic efficiency of a non-virus based specific chimeric multi-domain DNA transferred with apoptin in human hepatocellular carcinoma (HCC) HepG-2 cells in vitro and in mice H22 cells in vivo. METHODS: We firstly constructed the multi-domain recombinant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Encheng, Li, Xiao, Jin, Ningyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062862/ https://www.ncbi.nlm.nih.gov/pubmed/27752239 http://dx.doi.org/10.1186/s12935-016-0351-0

Ejemplares similares

DNA methylation biomarkers for hepatocellular carcinoma
por: Fan, Guorun, et al.
Publicado: (2018)

Decreased expression of Sushi Domain Containing 2 correlates to progressive features in patients with hepatocellular carcinoma
por: Liu, Xin-rui, et al.
Publicado: (2016)

Erythropoietin promoted the proliferation of hepatocellular carcinoma through hypoxia induced translocation of its specific receptor
por: Miao, Shuo, et al.
Publicado: (2017)

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance
por: Zhang, Wei, et al.
Publicado: (2020)

Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro
por: Xu, Yu-Jie, et al.
Publicado: (2021)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

β-TrCP-mediated ubiquitination and degradation of Dlg5 regulates hepatocellular carcinoma cell proliferation
por: Wang, Dongping, et al.
Publicado: (2019)

Significance of PRO2000/ANCCA expression, a novel proliferation-associated protein in hepatocellular carcinoma
por: Yang, Jie, et al.
Publicado: (2014)

Berberine regulates the protein expression of multiple tumorigenesis-related genes in hepatocellular carcinoma cell lines
por: Chuang, Tung-Yueh, et al.
Publicado: (2017)

Ring finger protein 152-dependent degradation of TSPAN12 suppresses hepatocellular carcinoma progression
por: Wan, Jian, et al.
Publicado: (2021)

MEK inhibition induced downregulation of MRP1 and MRP3 expression in experimental hepatocellular carcinoma
por: Lin, Shibo, et al.
Publicado: (2013)

The expression profiles and prognostic values of HSP70s in hepatocellular carcinoma
por: Wang, Ben, et al.
Publicado: (2021)

Effect of PLC-β1/CaM signaling pathway mediated by AT1R on the occurrence and development of hepatocellular carcinoma
por: Xu, Zhou-wei, et al.
Publicado: (2021)

A role for the NPM1/PTPN14/YAP axis in mediating hypoxia-induced chemoresistance to sorafenib in hepatocellular carcinoma
por: Zhang, Dengke, et al.
Publicado: (2022)

Ethanol extract of Ligustrum lucidum Ait. leaves suppressed hepatocellular carcinoma in vitro and in vivo
por: Tian, Guoyan, et al.
Publicado: (2019)

Two predictive precision medicine tools for hepatocellular carcinoma
por: Zhang, Zhiqiao, et al.
Publicado: (2019)

LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
por: He, Rong-Quan, et al.
Publicado: (2021)

YAP promotes multi-drug resistance and inhibits autophagy-related cell death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway
por: Zhou, Yuan, et al.
Publicado: (2019)

ZKSCAN3 drives tumor metastasis via integrin β4/FAK/AKT mediated epithelial–mesenchymal transition in hepatocellular carcinoma
por: Li, Jieqiong, et al.
Publicado: (2020)

The combination of Biochanin A and SB590885 potentiates the inhibition of tumour progression in hepatocellular carcinoma
por: Xiao, Yi, et al.
Publicado: (2020)

Expression of B7-H6 expression in human hepatocellular carcinoma and its clinical significance
por: Chen, Lujun, et al.
Publicado: (2018)

Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma
por: Fu, Xiu-Tao, et al.
Publicado: (2019)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

STK25 enhances hepatocellular carcinoma progression through the STRN/AMPK/ACC1 pathway
por: Zhang, Yichao, et al.
Publicado: (2022)

Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy
por: Zheng, Yanwen, et al.
Publicado: (2021)

Involvement of the epidermal growth factor receptor in the modulation of multidrug resistance in human hepatocellular carcinoma cells in vitro
por: Hoffmann, Katrin, et al.
Publicado: (2011)

Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinoma
por: Qian, E-Na, et al.
Publicado: (2016)

A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma
por: Ouyang, Guoqing, et al.
Publicado: (2020)

Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
por: Peng, Yanan, et al.
Publicado: (2021)

FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma
por: Wang, Liang, et al.
Publicado: (2022)

Three novel circRNAs upregulated in tissue and plasma from hepatocellular carcinoma patients and their regulatory network
por: Wang, Lianghai, et al.
Publicado: (2021)

Evaluating the role of RAD52 and its interactors as novel potential molecular targets for hepatocellular carcinoma
por: Li, Ping, et al.
Publicado: (2019)

RNAi silencing of c-Myc inhibits cell migration, invasion, and proliferation in HepG(2) human hepatocellular carcinoma cell line: c-Myc silencing in hepatocellular carcinoma cell
por: Zhao, Yan, et al.
Publicado: (2013)

Loss of PR55α promotes proliferation and metastasis by activating MAPK/AKT signaling in hepatocellular carcinoma
por: Zhao, JiangSheng, et al.
Publicado: (2021)

Association between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissues
por: Liu, Yongru, et al.
Publicado: (2015)

Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma
por: Hayashi, Takehiro, et al.
Publicado: (2017)

Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis
por: Luo, Yangkun, et al.
Publicado: (2016)

Expression of the Wnt ligands gene family and its relationship to prognosis in hepatocellular carcinoma
por: Dong, Jia-Jia, et al.
Publicado: (2019)

Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
por: Liu, Gao-Min, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h0cbtanutvdimnkkm58ko6nnau